News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,473 Results
Type
Article (59004)
Company Profile (208)
Press Release (686244)
Multimedia
Podcasts (169)
Webinars (28)
Section
Business (204805)
Career Advice (2984)
Deals (35139)
Drug Delivery (150)
Drug Development (82261)
Employer Resources (196)
FDA (16680)
Job Trends (15366)
News (347244)
Policy (33478)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2917)
Academic (2)
Accelerated approval (39)
Adcomms (34)
Allergies (166)
Alliances (50962)
ALS (195)
Alzheimer's disease (1811)
Antibody-drug conjugate (ADC) (366)
Approvals (16899)
Artificial intelligence (649)
Autoimmune disease (205)
Automation (46)
Bankruptcy (350)
Best Places to Work (12071)
BIOSECURE Act (22)
Biosimilars (206)
Biotechnology (134)
Bladder cancer (176)
Brain cancer (67)
Breast cancer (692)
Cancer (5317)
Cardiovascular disease (468)
Career advice (2548)
Career pathing (44)
CAR-T (316)
CDC (63)
Celiac Disease (1)
Cell therapy (854)
Cervical cancer (40)
Clinical research (70207)
Collaboration (1958)
Company closure (6)
Compensation (1200)
Complete response letters (79)
COVID-19 (2875)
CRISPR (110)
C-suite (989)
Cystic fibrosis (152)
Data (6809)
Decentralized trials (2)
Denatured (57)
Depression (168)
Diabetes (550)
Diagnostics (7105)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (48)
Drug discovery (305)
Drug pricing (214)
Drug shortages (34)
Duchenne muscular dystrophy (271)
Earnings (86874)
Editorial (67)
Employer branding (25)
Employer resources (170)
Events (123035)
Executive appointments (1081)
FDA (20025)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (25)
Funding (1637)
Gene editing (231)
Generative AI (66)
Gene therapy (714)
GLP-1 (1144)
Government (5082)
Grass and pollen (8)
Guidances (390)
Healthcare (20117)
HIV (74)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (303)
Immuno-oncology (79)
Indications (139)
Infectious disease (3193)
Inflammatory bowel disease (219)
Inflation Reduction Act (16)
Influenza (130)
Intellectual property (267)
Interviews (596)
IPO (16600)
IRA (58)
Job creations (3651)
Job search strategy (2071)
JPM (67)
Kidney cancer (20)
Labor market (95)
Layoffs (604)
Leadership (44)
Legal (8002)
Liver cancer (100)
Longevity (23)
Lung cancer (707)
Lymphoma (400)
Machine learning (48)
Management (64)
Manufacturing (911)
MASH (189)
Medical device (14216)
Medtech (14289)
Mergers & acquisitions (19698)
Metabolic disorders (1469)
mRNA (189)
Multiple sclerosis (181)
NASH (23)
Neurodegenerative disease (390)
Neuropsychiatric disorders (107)
Neuroscience (3246)
Neurotech (1)
NextGen: Class of 2026 (7009)
Non-profit (4907)
Now hiring (72)
Obesity (717)
Opinion (339)
Ovarian cancer (175)
Pain (233)
Pancreatic cancer (253)
Parkinson's disease (329)
Partnered (35)
Patents (551)
Patient recruitment (569)
Peanut (64)
People (61317)
Pharmaceutical (50)
Pharmacy benefit managers (29)
Phase 1 (21689)
Phase 2 (30684)
Phase 3 (23423)
Pipeline (6404)
Policy (345)
Postmarket research (2794)
Preclinical (9430)
Press Release (71)
Prostate cancer (275)
Psychedelics (61)
Radiopharmaceuticals (309)
Rare diseases (1034)
Real estate (5895)
Recruiting (80)
Regulatory (25341)
Reports (64)
Research institute (2642)
Resumes & cover letters (448)
Rett syndrome (32)
RNA editing (19)
RSV (90)
Schizophrenia (166)
Series A (282)
Series B (205)
Service/supplier (10)
Sickle cell disease (109)
Special edition (26)
Spinal muscular atrophy (172)
Sponsored (45)
Startups (3821)
State (2)
Stomach cancer (20)
Supply chain (121)
Tariffs (91)
The Weekly (109)
Vaccines (1117)
Venture capital (102)
Weight loss (481)
Women's health (103)
Worklife (23)
Date
Today (122)
Last 7 days (623)
Last 30 days (3236)
Last 365 days (31866)
2026 (6487)
2025 (32088)
2024 (36701)
2023 (41602)
2022 (52826)
2021 (57411)
2020 (55825)
2019 (48914)
2018 (37040)
2017 (34177)
2016 (33755)
2015 (39284)
2014 (31960)
2013 (27404)
2012 (28847)
2011 (29354)
2010 (27629)
Location
Africa (1000)
Alabama (91)
Alaska (7)
Arizona (304)
Arkansas (15)
Asia (43901)
Australia (8132)
California (12119)
Canada (3467)
China (1219)
Colorado (514)
Connecticut (535)
Delaware (358)
Europe (101175)
Florida (1812)
Georgia (395)
Hawaii (4)
Idaho (57)
Illinois (973)
India (81)
Indiana (571)
Iowa (22)
Japan (476)
Kansas (128)
Kentucky (46)
Louisiana (36)
Maine (85)
Maryland (1508)
Massachusetts (8878)
Michigan (370)
Minnesota (683)
Mississippi (7)
Missouri (148)
Montana (31)
Nebraska (29)
Nevada (135)
New Hampshire (89)
New Jersey (3293)
New Mexico (31)
New York (3210)
North Carolina (1609)
North Dakota (9)
Northern California (5956)
Ohio (363)
Oklahoma (21)
Oregon (40)
Pennsylvania (2428)
Puerto Rico (24)
Rhode Island (49)
South America (1349)
South Carolina (71)
South Dakota (1)
Southern California (4757)
Tennessee (190)
Texas (1906)
United States (43460)
Utah (366)
Vermont (1)
Virginia (298)
Washington D.C. (83)
Washington State (986)
West Virginia (4)
Wisconsin (134)
Wyoming (2)
745,473 Results for "tekla life sciences investors formerly known as h and q life sciences investors".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Report: U.S. Life Sciences Job Market Report Q4 2025
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
January 19, 2026
·
1 min read
·
BioSpace Insights
Press Releases
Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum
March 9, 2026
·
1 min read
Job Trends
BioSpace
Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs
BioSpace
has revealed its new 2026 Hotbed Maps, showcasing seven regional life sciences hot spots.
January 20, 2026
·
2 min read
·
Chantal Dresner
Press Releases
Anavex Life Sciences to Present at the Citizens Life Sciences Conference
March 3, 2026
·
3 min read
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
L7 Informatics CEO explains why the next wave of life sciences innovation depends on digital unified platforms that orchestrate workflows, contextualize data, and enable AI-actionable operations.
February 12, 2026
·
1 min read
Press Releases
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT
March 10, 2026
·
1 min read
Press Releases
Caris Life Sciences to Attend Q4 2025 Investor Conferences
November 18, 2025
·
1 min read
Press Releases
TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors
February 10, 2026
·
7 min read
Job Trends
Report: U.S. Life Sciences Job Market Report Q3 2025
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
October 16, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
February 25, 2026
·
2 min read
1 of 74,548
Next
